Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Theraclion SA (TCLIF)
OTHER OTC:TCLIF
Holding TCLIF?
Track your performance easily
TCLIF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.32 - $0.59
Previous CloseN/A
Volume1.00K
Average Volume (3M)0.00
Market Cap
$11.20M
Enterprise Value$11.96M
Total Cash (Recent Filing)$1.30M
Total Debt (Recent Filing)$2.09M
Price to Earnings (P/E)―
Beta1.08
Next Earnings
Mar 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume0
Standard Deviation485.79
R-Squared0.00196
Alpha116.59
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)21.39
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.07
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-8.57
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
TCLIF FAQ
What was Theraclion SA’s price range in the past 12 months?
Theraclion SA lowest stock price was $0.32 and its highest was $0.59 in the past 12 months.
What is Theraclion SA’s market cap?
Theraclion SA’s market cap is $11.20M.
When is Theraclion SA’s upcoming earnings report date?
Theraclion SA’s upcoming earnings report date is Mar 19, 2025 which is in 63 days.
How were Theraclion SA’s earnings last quarter?
Theraclion SA released its earnings results on Oct 30, 2024. The company reported -$0.054 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.054.
Is Theraclion SA overvalued?
According to Wall Street analysts Theraclion SA’s price is currently Overvalued.
Does Theraclion SA pay dividends?
Theraclion SA does not currently pay dividends.
What is Theraclion SA’s EPS estimate?
Theraclion SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Theraclion SA have?
Currently, no data Available
What happened to Theraclion SA’s price movement after its last earnings report?
Theraclion SA reported an EPS of -$0.054 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Theraclion SA?
Currently, no hedge funds are holding shares in TCLIF
---
Company Description
Theraclion SA
Théraclion SA develops, manufactures, and markets oncological medical equipment. Its products are marketed under the brands of EchoPulse and EPack. EchoPulse is a device used for non-invasive and outpatient treatment of fibroadenoma of the breast and thyroid nodules. EPack is a single-use disposable patented system used for cooling and coupling functions. The company was founded by François Lacoste and Jérôme Lebon on August 5, 2004 and is headquartered in Malakoff, France.
---
Astellas Pharma
―
Zomedica Pharmaceuticals
―
Cyclo Therapeutics
―
Advaxis
―
Cellectar Biosciences
―
---